Inhibition of benzo(a)pyrene Carcinogenesis in rats with vitamin C

Journal of Cancer Research and Clinical Oncology

Volumn 97, Issue 1, 1980, Pages 91-96

  Kallistratos, G ^a   Fasske, E ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Benzo(a)pyrene carcinogenesis; Vitamin C tumor inhibition

Indexed keywords

ASCORBIC ACID; BENZO[A]PYRENE;

ANIMAL EXPERIMENT; CANCER; CANCER INHIBITION; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; DRUG ANTAGONISM; FIBROSARCOMA; INHIBITION; RAT; RHABDOMYOSARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ASCORBIC ACID; BENZOPYRENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSARCOMA; NEOPLASMS, EXPERIMENTAL; RATS; RHABDOMYOSARCOMA; SARCOMA, EXPERIMENTAL;

EID: 0018831870     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF00411283     Document Type: Article

References (12)

1. Ascorbic acid, cell proliferation, and cancer
2. Ascorbic acid and the Glycosaminoglycans. An orthomolecular approach to cancer and other diseases
3. The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance
4. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer
5. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: Double complete regression induced by high-dose ascorbic acid therapy
6. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer
7. Alcoholic cirrhosis: complicated by polycythemia vera and then myelogenous leukemia and tolerance of large doses of Vitamin C
8. Die Bedeutung der cis-Aconitsäure für die biologische Inaktivierung der 3,4-Benzopyren-Kanzerogenese
9. Prevention of 3,4-benzopyrene carcinogenesis in presence of Putrescine
10. Biologische Inaktivierung kanzerogener Stoffe
11. Plädoyer für Vitamin C